Prognostic Impact of CXCR7 and CXCL12 Expression in Patients with Esophageal Adenocarcinoma
Authors:
- 11 March 2021
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (9) , 4943-4951
Abstract
Chemokines are major regulators of cell trafficking and adhesion. The chemokine CXCL12 and its receptors, CXCR4 and CXCR7, have been reported as biomarkersKeywords
This publication has 28 references indexed in Scilit:
- Clinical significance of CXCL-8/CXCR-2 network in esophageal squamous cell carcinomaSurgery, 2013
- CXCR7 expression in esophageal cancerJournal of Translational Medicine, 2013
- Interleukin-6 as a Therapeutic Target in Human Ovarian CancerClinical Cancer Research, 2011
- CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?Clinical Cancer Research, 2011
- Chemokines and chemokine receptors: new insights into cancer-related inflammationTrends in Molecular Medicine, 2010
- A Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate CancerCancer Research, 2007
- A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor developmentJournal of Experimental Medicine, 2006
- Tumor-Cell Homing to Lymph Nodes and Bone Marrow and CXCR4 Expression in Esophageal CancerJNCI: Journal of the National Cancer Institute, 2005
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958